🔎 Trials Near Me

Beranda › Penyakit Ginjal Kronis › Utah

Uji klinis Penyakit Ginjal Kronis di Utah

7 studi untuk Penyakit Ginjal Kronis mencari peserta di lokasi di Utah.

Kota di Utah

Teks studi resmi (Bahasa Inggris)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Ogden Clinic - Canyon View, Ogden
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, South Salt Lake
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06742723

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  • Primary Children's Hospital, Salt Lake City
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07107945

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  • Research Site, South Salt Lake
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07753993

Sit Less, Interact and Move More (SLIMM) 2 Study

  • University of Utah, Salt Lake City
Menerima pesertaFase 2
Usia 20 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05173714

Study of BHV-1400 in IgA Nephropathy

  • Site-016, Salt Lake City
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT07054684

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

  • Primary Childrens Hospital Outpatient Services, Salt Lake City
Menerima pesertaFase 3
Usia 0 hingga 18 · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT03633708

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.